Risk factors for neurological complications in complete hemolytic uremic syndrome caused by Escherichia coli O157

Pediatrics International

Volumn 51, Issue 2, 2009, Pages 216-219

  Yamamoto, Takehisa ^a   Satomura, Kenichi ^b   Okada, Shintaro ^c   Ozono, Keiichi ^c  

^a Minoh City Hospital   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Encephalopathy; Escherichia coli O157 infection; Hemolytic uremic syndrome; Neurological complication; Predictive factor; Risk factor

Indexed keywords

C REACTIVE PROTEIN; CREATININE; LACTATE DEHYDROGENASE;

ARTICLE; BLOODY DIARRHEA; BRAIN DISEASE; CHILD; CLINICAL FEATURE; COLITIS; CREATININE BLOOD LEVEL; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; FEMALE; GENDER; GROUPS BY AGE; HEMATURIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; OLIGURIA; PALLOR; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SCHOOL CHILD;

BRAIN DISEASES; CHILD; CREATININE; ESCHERICHIA COLI O157; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; L-LACTATE DEHYDROGENASE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 63549147220     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02690.x     Document Type: Article

References (16)

1. Riley LW, Remis RS, Helgerson SD et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 1983 308 : 681 5.
2. Su C, Bradt LJ. Escherichia coli O157: H7 infection in human. Ann. Intern. Med. 1995 123 : 698 714.
3. Bell BP, Griffin PM, Lozano P et al. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157: H7 infections. Pediatrics 1997 100 : 127 (E12).
4. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N. Engl. J. Med. 2000 342 : 1930 36.
5. Ikeda K, Ida O, Kimoto K, Takatorige T, Nakanishi N, Tatara K. Effect of early fosfomycine treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157: H7 infection. Clin. Nephrol. 1999 52 : 357 62.
6. Igarashi T, Inatomi J, Wake A, Takamizuka M, Katayama H, Iwata T. Failure of pre-diarrheal antibiotics to prevent hemolytic uremic syndrome in serologically proven Escherichia coli O157: H7 gastrointestinal infection. J. Pediatr. 1999 135 : 768 9.
7. Armstrong GD, Rowe PC, Goodyer P et al. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) PK-trisaccharide receptors attached to chromosorb for preventing hemolytic uremic syndrome. J. Infect. Dis. 1995 171 : 1042 5.
8. Ito H, Takeda T, Honda M et al. Preventive effect of TAK-751S on complications of hemorrhagic colitis (results of clinical study of TAK-751S). Jpn. J. Antibiot. 2002 55 : 203 27.
9. Cimolai N, Morrison BJ, Carter JE. Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome. Pediatrics 1992 90 : 616 21.
10. Donohue-Rolfe A, Kondova I, Mukherjee J et al. Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2. Infect. Immun. 1999 67 : 3645 48.
11. Sheoran AS, Chapman S, Singh P et al. Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing STx2 variants. Infect. Immun. 2003 71 : 3125 30.
12. Yamamoto T, Nagayama K, Satomura K, Honda T, Okada S. Increased serum IL-10 and endothelin levels in hemolytic uremic syndrome caused by Escherichia coli O 157. Nephron 2000 84 : 326 32.
13. van der Kar NCAJ, Sauerwein RW, Demacker PNM et al. Plasma cytokine levels in hemolytic uremic syndrome. Nephron 1995 71 : 309 13.
14. Lopez EL, Contrini MM, Deroto S et al. Tumor necrosis factor concentrations in hemolytic uremic syndrome patients and children with bloody diarrhea in Argentina. Pediatr. Infect. Dis. J. 1995 14 : 594 8.
15. Tzipori S, Chow CW, Powell HR. Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets. J. Clin. Pathol. 1988 41 : 1099 103.
16. Fujii J, Kita T, Yoshida S et al. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli 157:H7 in mitomycin-treated mice. Infect. Immun. 1994 62 : 3447 53.